AMAG Pharmaceuticals Performance
The firm owns a Beta (Systematic Risk) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and AMAG Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days AMAG Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, AMAG Pharmaceuticals is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Quick Ratio | 1.46 | |
| Fifty Two Week Low | 4.41 | |
| Target High Price | 13.75 | |
| Fifty Two Week High | 13.80 | |
| Target Low Price | 5.00 |
AMAG |
AMAG Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in AMAG Pharmaceuticals on January 25, 2024 and sell it today you would earn a total of 100.00 from holding AMAG Pharmaceuticals or generate -100.0% return on investment over 90 days. AMAG Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than AMAG, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AMAG Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AMAG Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AMAG Pharmaceuticals, and traders can use it to determine the average amount a AMAG Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AMAG |
Based on monthly moving average AMAG Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AMAG Pharmaceuticals by adding AMAG Pharmaceuticals to a well-diversified portfolio.
AMAG Pharmaceuticals Fundamentals Growth
AMAG Stock prices reflect investors' perceptions of the future prospects and financial health of AMAG Pharmaceuticals, and AMAG Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AMAG Stock performance.
| Return On Equity | -62.88 | |||
| Return On Asset | -3.06 | |||
| Profit Margin | (77.18) % | |||
| Operating Margin | (13.88) % | |||
| Current Valuation | 619.79 M | |||
| Shares Outstanding | 34.73 M | |||
| Price To Earning | (322.21) X | |||
| Price To Book | 1.85 X | |||
| Price To Sales | 1.59 X | |||
| Revenue | 300.12 M | |||
| EBITDA | (35.97 M) | |||
| Cash And Equivalents | 168.9 M | |||
| Cash Per Share | 4.86 X | |||
| Total Debt | 311.22 M | |||
| Debt To Equity | 1.22 % | |||
| Book Value Per Share | 7.42 X | |||
| Cash Flow From Operations | (26.73 M) | |||
| Earnings Per Share | (6.77) X | |||
| Total Asset | 2.48 B | |||
| Retained Earnings | (1.04 B) | |||
| Current Asset | 606.67 M | |||
| Current Liabilities | 245.92 M | |||
Things to note about AMAG Pharmaceuticals performance evaluation
Checking the ongoing alerts about AMAG Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AMAG Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AMAG Pharmaceuticals is not yet fully synchronised with the market data | |
| AMAG Pharmaceuticals has some characteristics of a very speculative penny stock | |
| AMAG Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 300.12 M. Net Loss for the year was (231.62 M) with profit before overhead, payroll, taxes, and interest of 219.35 M. | |
| AMAG Pharmaceuticals currently holds about 168.9 M in cash with (26.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.86. | |
| Over 98.0% of the company shares are held by institutions such as insurance companies |
- Analyzing AMAG Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AMAG Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining AMAG Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AMAG Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AMAG Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AMAG Pharmaceuticals' stock. These opinions can provide insight into AMAG Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AMAG Pharmaceuticals information on this page should be used as a complementary analysis to other AMAG Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in AMAG Stock
If you are still planning to invest in AMAG Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AMAG Pharmaceuticals' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |